Table 3 Univariate and multivariate analysis of overall survival and recurrence free survival

Overall survival

Ang-2

<0.001

ns

VEGF

0.002

ns

sVEGFR-2

0.001

ns

VEGF/sVEGFR-2

<0.001

ns

Ang-2/VEGF

0.005

ns

Ang-2/sVEGFR-2

0.002

ns

Ascites

0.005

ns

Stage

0.005

ns

Primary residual tumor

<0.001

0.004

None

< 1 cm

<0.001

6.38

1.61-25.225

0.008

>1 cm

<0.001

8.10

2.346-27.814

0.001

Chemotherapy response

<0.001

<0.001

Complete response

Partial response

<0.001

5.192

1.488-18.113

0.010

Stable disease

<0.001

44.71

6.008-332.56

<0.001

Progressive disease

<0.001

16.80

4.238-66.522

<0.001

Recurrence free survival

Ang-2

0.001

ns

VEGF

0.019

ns

sVEGFR-2

0.031

ns

VEGFR/sVEGFR-2

<0.001

ns

Ang-2/VEGF

0.022

ns

Ang-2/sVEGFR-2

<0.001

ns

Ascites

0.001

ns

Histological grade

0.001

ns

Stage

<0.001

ns

Primary residual tumor

<0.001

<0.001

None

< 1 cm

<0.001

6.81

2.112-21.961

0.001

>1 cm

<0.001

7.87

2.926-21.163

<0.001

Chemotherapy response

0.012

ns

Complete response

Partial response

0.007

Stable disease

0.158 (n = 1)